Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% ...

Moderna CFO Jamey Mock says it's too soon to gauge how the FDA's refusal to review its flu vaccine impacts the company's 2028 ...

The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel ...

The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

Breakthrough personalized mRNA vaccine cuts melanoma recurrence risk by 50% when combined with Keytruda, Moderna CEO reveals ...

Moderna (MRNA) stock trades flat as the company beats with its Q4 2025 results and reaffirms 2026 growth target despite FDA setback for flu shot. Read more here.

The post Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It. appeared first on Reason.com. FX’s “Love Story” explores a romance frozen in time, ...

News is latest sign of the agency's heightened scrutiny of vaccines ...